{"id":"https://openalex.org/W1501681810","doi":"https://doi.org/10.1111/bcp.12427","title":"Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 ( A lliance)","display_name":"Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 ( A lliance)","publication_year":2014,"publication_date":"2014-05-16","ids":{"openalex":"https://openalex.org/W1501681810","doi":"https://doi.org/10.1111/bcp.12427","mag":"1501681810","pmid":"https://pubmed.ncbi.nlm.nih.gov/24838014","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4243874"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.12427","doi":"https://doi.org/10.1111/bcp.12427","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.12427","pdf_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.12427","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.12427","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100333262","display_name":"Xiaofeng Wang","orcid":"https://orcid.org/0000-0003-0750-8360","observed_orcids":["https://orcid.org/0000-0003-0750-8360"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaofeng Wang","raw_affiliation_strings":["University of Iowa; Iowa City; IA; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Iowa; Iowa City; IA; USA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031078301","display_name":"Kouros Owzar","orcid":"https://orcid.org/0000-0002-3340-1287","observed_orcids":["https://orcid.org/0000-0002-3340-1287","https://orcid.org/0000-0002-4641-786X"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kouros Owzar","raw_affiliation_strings":["Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049781902","display_name":"Pankaj Gupta","orcid":"https://orcid.org/0000-0001-9058-211X","observed_orcids":["https://orcid.org/0000-0001-9058-211X"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4210140408","display_name":"Minneapolis VA Medical Center","ror":"https://ror.org/032b8d361","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210117246","https://openalex.org/I4210117924","https://openalex.org/I4210140408"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pankaj Gupta","raw_affiliation_strings":["Minneapolis Veterans Administration Medical Center University of Minnesota Minneapolis MN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Minneapolis Veterans Administration Medical Center University of Minnesota Minneapolis MN USA","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4210140408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072420982","display_name":"Richard A. Larson","orcid":"https://orcid.org/0000-0001-9168-3203","observed_orcids":["https://orcid.org/0000-0001-9168-3203"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A. Larson","raw_affiliation_strings":["University of Chicago , Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago , Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051534528","display_name":"Flora A. Mulkey","orcid":"https://orcid.org/0000-0003-0760-2648","observed_orcids":["https://orcid.org/0000-0003-0760-2648"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Flora Mulkey","raw_affiliation_strings":["Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC, USA","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112385025","display_name":"Antonius Arthur Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonius A. Miller","raw_affiliation_strings":["Wake Forest University School of Medicine, Winston, Salem, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest University School of Medicine, Winston, Salem, NC, USA","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080500055","display_name":"Lionel D. Lewis","orcid":"https://orcid.org/0000-0003-1164-5157","observed_orcids":["https://orcid.org/0000-0003-1164-5157"]},"institutions":[{"id":"https://openalex.org/I4390039367","display_name":"Dartmouth Cancer Center","ror":"https://ror.org/044b05b34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039367"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lionel D. Lewis","raw_affiliation_strings":["The Norris Cotton Cancer Center and Geisel School of Medicine at Dartmouth Lebanon NH USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Norris Cotton Cancer Center and Geisel School of Medicine at Dartmouth Lebanon NH USA","institution_ids":["https://openalex.org/I4390039367"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113876581","display_name":"David Duane Hurd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Hurd","raw_affiliation_strings":["Wake Forest University School of Medicine, Winston, Salem, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest University School of Medicine, Winston, Salem, NC, USA","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026151069","display_name":"Ravi Vij","orcid":"https://orcid.org/0000-0001-8795-3610","observed_orcids":["https://orcid.org/0000-0001-8795-3610","https://orcid.org/0000-0001-6358-2392"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi Vij","raw_affiliation_strings":["Washington University, School of Medicine, St. Louis, MO, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University, School of Medicine, St. Louis, MO, USA;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068268371","display_name":"Mark J. Ratain","orcid":"https://orcid.org/0000-0002-0938-4392","observed_orcids":["https://orcid.org/0000-0002-0938-4392"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark J. Ratain","raw_affiliation_strings":["University of Chicago , Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago , Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082380296","display_name":"Daryl J. Murry","orcid":"https://orcid.org/0000-0002-4169-5027","observed_orcids":["https://orcid.org/0000-0002-4169-5027"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daryl J. Murry","raw_affiliation_strings":["University of Iowa; Iowa City; IA; USA"],"raw_orcid":"https://orcid.org/0000-0002-4169-5027","affiliations":[{"raw_affiliation_string":"University of Iowa; Iowa City; IA; USA","institution_ids":["https://openalex.org/I126307644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5082380296"],"corresponding_institution_ids":["https://openalex.org/I126307644"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.6806,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.63285458,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"78","issue":"5","first_page":"1005","last_page":"1013"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.3230000138282776,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.3230000138282776,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.3091000020503998,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.12269999831914902,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vatalanib","display_name":"vatalanib","score":1.0},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9440000057220459},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.9789999723434448},{"id":"https://openalex.org/keywords/autoinduction","display_name":"autoinduction","score":0.7720000147819519},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.7009999752044678},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/exposure-toxicity-relationship","display_name":"exposure-toxicity relationship","score":0.9169999957084656},{"id":"https://openalex.org/keywords/pharmacokinetic-variability","display_name":"pharmacokinetic variability","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C2776239304","wikidata":"https://www.wikidata.org/wiki/Q6954915","display_name":"NONMEM","level":3,"score":0.8641355633735657},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8569092750549316},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6070231795310974},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5898633003234863},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5765533447265625},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4125079810619354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3743235468864441},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bcp.12427","doi":"https://doi.org/10.1111/bcp.12427","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.12427","pdf_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.12427","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4243874","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4243874","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:24838014","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24838014","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1111/bcp.12427","doi":"https://doi.org/10.1111/bcp.12427","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.12427","pdf_url":"https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.12427","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1410909402","display_name":"Alliance Statistics and Data Management Center","funder_award_id":"U10CA180882","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1482806480","display_name":"WUMC Cancer and Leukemia Group B","funder_award_id":"U10CA077440","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2645941341","display_name":"Cancer and Leukemia Group B","funder_award_id":"U10CA003927","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3054160986","display_name":"Cancer and Leukemia Group B Statistical Center","funder_award_id":"U10CA033601","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3075028336","display_name":"University of Iowa CALGB Institutional Grant","funder_award_id":"U10CA047642","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5979052305","display_name":"CANCER AND LEUKEMIA GROUP B (CALGB)","funder_award_id":"U10CA004326","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6593449295","display_name":"Cancer and Leukemia Group B","funder_award_id":"U10CA031946","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7479992879","display_name":"CANCER AND LEUKEMIA GROUP B--MINNESOTA ONCOLOGY GROUP","funder_award_id":"U10CA016450","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7490599067","display_name":"Cancer and Leukemia Group B","funder_award_id":"U10CA041287","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8740451518","display_name":"Alliance for Clinical Trials in Oncology Operations Center","funder_award_id":"U10CA180821","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000872750","display_name":"The Alliance NCTN Biorepository and Biospecimen Resource","funder_award_id":"U24CA196171","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1501681810.pdf","grobid_xml":"https://content.openalex.org/works/W1501681810.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W182858095","https://openalex.org/W1507842220","https://openalex.org/W1567732942","https://openalex.org/W1858095914","https://openalex.org/W1866616545","https://openalex.org/W1868766650","https://openalex.org/W1972028081","https://openalex.org/W1974630669","https://openalex.org/W1976871372","https://openalex.org/W1982992637","https://openalex.org/W1991958278","https://openalex.org/W1995081817","https://openalex.org/W2002474280","https://openalex.org/W2010549888","https://openalex.org/W2022108422","https://openalex.org/W2026812405","https://openalex.org/W2038922474","https://openalex.org/W2039625166","https://openalex.org/W2051975554","https://openalex.org/W2080039717","https://openalex.org/W2083083094","https://openalex.org/W2091872802","https://openalex.org/W2093570795","https://openalex.org/W2094022450","https://openalex.org/W2098049179","https://openalex.org/W2109597925","https://openalex.org/W2116505170","https://openalex.org/W2121276143","https://openalex.org/W2121690400","https://openalex.org/W2132416188","https://openalex.org/W2134294082","https://openalex.org/W2147178092"],"related_works":["https://openalex.org/W2115986506","https://openalex.org/W2080039717","https://openalex.org/W2281965870","https://openalex.org/W2590400320","https://openalex.org/W2685961074","https://openalex.org/W4388537857","https://openalex.org/W1975308010","https://openalex.org/W2690406299","https://openalex.org/W2775344839","https://openalex.org/W2801404544"],"abstract_inverted_index":{"AIMS:":[0],"Vatalanib":[1,218],"is":[2],"an":[3,57],"oral":[4,145,164,181],"anti-angiogenesis":[5],"agent":[6],"that":[7],"inhibits":[8],"vascular":[9],"endothelial":[10],"growth":[11],"factor":[12],"receptor":[13],"tyrosine":[14],"kinases,":[15],"which":[16],"in":[17,26,41,48,64,72,144],"patients":[18,49,66,122],"showed":[19],"auto":[20,227],"induction":[21,228],"of":[22,62,127,201,226,236],"metabolism":[23],"and":[24,38,44,80,111,141,162,172,223],"variability":[25],"pharmacokinetic":[27],"(PK)":[28],"disposition.":[29],"The":[30,101,157,179],"objective":[31],"was":[32,56,90,104,147,215,229],"to":[33,149,190,210,232],"characterize":[34],"the":[35,150,202,224,237],"population":[36,158],"PK":[37,88],"time-dependent":[39,142],"change":[40,143],"vatalanib":[42,63,82,151,206],"clearance":[43,146,165,182],"assess":[45],"exposure-toxicity":[46],"relationship":[47,200,214],"with":[50,95,137,205,234],"myelodysplastic":[51],"syndrome":[52],"(MDS).":[53],"METHODS:":[54],"This":[55],"open-label":[58],"phase":[59],"II":[60],"study":[61],"MDS":[65],"receiving":[67],"750-1250":[68],"mg":[69],"once":[70],"daily":[71],"28-day":[73],"cycles.":[74],"Serial":[75],"blood":[76],"samples":[77],"were":[78,118,166,220],"obtained":[79],"plasma":[81,152],"concentrations":[83],"measured":[84],"by":[85],"HPLC.":[86],"Population":[87],"analysis":[89],"performed":[91],"using":[92,106],"nonmem":[93],"7.2":[94],"FO":[96],"estimation":[97],"since":[98],"FOCE":[99],"failed.":[100],"final":[102],"model":[103,136],"evaluated":[105],"goodness-of-fit":[107],"plots,":[108],"bootstrap":[109],"analysis,":[110],"visual":[112],"predictive":[113],"check.":[114],"RESULTS:":[115],"Pharmacokinetic":[116],"data":[117,194],"complete":[119],"for":[120,160],"137":[121],"(86":[123],"M,":[124],"51":[125],"F),":[126],"median":[128],"age":[129],"70":[130],"years":[131],"(range":[132],"20-91).":[133],"A":[134],"one-compartment":[135],"lagged":[138],"first-order":[139],"absorption":[140],"fitted":[148],"concentration":[153],"versus":[154],"time":[155],"data.":[156],"means":[159],"pre-induction":[161],"post-induction":[163],"24.1":[167],"l":[168,174],"h(-1)":[169,175],"(range:":[170,176,185],"9.6-45.5)":[171],"54.9":[173],"39.8-75.6),":[177],"respectively.":[178],"apparent":[180],"increased":[183],"2.3-fold,":[184],"1.7-4.1-fold)":[186],"from":[187],"first":[188],"dose":[189],"steady":[191],"state.":[192],"Our":[193],"did":[195],"not":[196,230],"identify":[197],"a":[198,213],"significant":[199],"predefined":[203],"covariates":[204],"pharmacokinetics,":[207],"although":[208],"power":[209],"detect":[211],"such":[212],"limited.":[216],"CONCLUSIONS:":[217],"pharmacokinetics":[219],"highly":[221],"variable":[222],"extent":[225],"determined":[231],"correlate":[233],"any":[235],"pre-defined":[238],"covariates.":[239]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}